SpringerLink
Log in

Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Malignant melanoma of the skin preferentially metastasises via the lymphatic system. Novel molecular biomarkers, which are involved in malignant transformation, proliferation, angiogenesis and lymphangiogenesis, are currently under investigation to elucidate the risk for lymph node metastasis. To this end, the vascular endothelial growth factors VEGF-C and VEGF-D have been identified to promote lymphangiogenesis and lymphatic spread through activation of its receptor, Vascular endothelial growth factor receptor-3 (VEGFR-3). Prompted by this assumption, we estimated the degree of lymphangiogenesis by semiquantitative immunohistochemical analysis of the expression of VEGFR-3 and the panvascular marker CD31 in primary cutaneous melanoma (n=26) and correlated these findings with the sentinel lymph node (SLN) status. The cohort was selected for matched prognostic markers in SLN-positive and SLN-negative patients. In contrast to other studies, we observed an inverse correlation between expression of these markers with lymph node metastases. Additionally, no difference between intratumoral versus peritumoral CD31- or VEGFR-3 expression on blood vessels versus lymphatic capillaries could be detected. Interestingly, VEGFR-3 upregulation was not restrained to vascular structures but also appeared on tumor cells. In summary, in our series VEGFR-3/CD31 immunohistochemical staining of primary melanoma does not serve as a valid marker to predict lymph node involvement. As lymphatic spread is a complex, multi-step process, several different biomarkers have to be combined to define new prognostic subgroups in cutaneous melanoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (France)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

VEGFR-3:

Vascular endothelial growth factor receptor-3

VEGF:

Vascular endothelial growth factor

Reference

  1. Achen MG, Jeltsch M, Kukk E et al (1998) Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) Proc Natl Acad Sci USA 20;95:548–553

    Article  Google Scholar 

  2. Achen MG, Williams RA, Minekus MP et al (2001) Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis J Pathol 193:147–154

    Article  PubMed  CAS  Google Scholar 

  3. Carlson JA, Ross JS, Slominski A et al (2005) Molecular diagnostics in melanoma J Am Acad Dermatol 52:743–775

    Article  PubMed  Google Scholar 

  4. Chang LK, Garcia-Cardena G, Farnebo F et al (2004) Dose-dependent response of FGF−2 for lymphangiogenesis Proc Natl Acad Sci U S A 101:11658–11663

    Article  PubMed  CAS  Google Scholar 

  5. Clarijs R, Schalkwijk L, Hofmann UB et al (2002) Induction of vascular endothelial growth factor receptor−3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma Cancer Res 62:7059–7065

    PubMed  CAS  Google Scholar 

  6. Dadras SS, Paul T, Bertoncini J et al (2003) Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival Am J Pathol 162:1951–1960

    PubMed  Google Scholar 

  7. de Waal RM, van Altena MC, Erhard H et al (1997) Lack of lymphangiogenesis in human primary cutaneous melanoma. Consequences for the mechanism of lymphatic dissemination Am J Pathol 150:1951–1957

    PubMed  Google Scholar 

  8. He Y, Kozaki K, Karpanen T et al (2002) Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling J Natl Cancer Inst 94:819–825

    PubMed  CAS  Google Scholar 

  9. He Y, Rajantie I, Pajusola K et al (2005) Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels Cancer Res 65:4739–4746

    Article  PubMed  CAS  Google Scholar 

  10. Joukov V, Pajusola K, Kaipainen A et al (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR−3) and KDR (VEGFR−2) receptor tyrosine kinases EMBO J 15:290–298

    PubMed  CAS  Google Scholar 

  11. Kajiya K, Hirakawa S, Ma B et al (2005) Hepatocyte growth factor promotes lymphatic vessel formation and function EMBO J 24:2885–2895

    Article  PubMed  CAS  Google Scholar 

  12. Kesmodel SB, Karakousis GC, Botbyl JD et al (2005) Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas Ann Surg Oncol 12:449–458

    Article  PubMed  Google Scholar 

  13. Longatto FA, Martins A, Costa SM et al (2005) VEGFR−3 expression in breast cancer tissue is not restricted to lymphatic vessels Pathol Res Pract 201:93–99

    Article  CAS  Google Scholar 

  14. Makinen T, Jussila L, Veikkola T et al (2001) Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor−3 Nat Med 7:199–205

    Article  PubMed  CAS  Google Scholar 

  15. Mandriota SJ, Jussila L, Jeltsch M et al (2001) Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis EMBO J 20:672–682

    Article  PubMed  CAS  Google Scholar 

  16. Manley PW, Bold G, Bruggen J et al (2004) Advances in the structural biology, design and clinical development of VEGF-R kinase inhibitors for the treatment of angiogenesis Biochim Biophys Acta 1697:17–27

    PubMed  CAS  Google Scholar 

  17. Padera TP, Kadambi A, di Tomaso E et al (2002) Lymphatic metastasis in the absence of functional intratumor lymphatics Science 296:1883–1886

    Article  PubMed  CAS  Google Scholar 

  18. Paget S (1989) The distribution of secondary growths in cancer of the breast 1889. Cancer Metastasis Rev 8:98–101

    CAS  Google Scholar 

  19. Papoutsi M, Siemeister G, Weindel K et al (2000) Active interaction of human A375 melanoma cells with the lymphatics in vivo Histochem Cell Biol 114:373–385

    PubMed  CAS  Google Scholar 

  20. Partanen TA, Alitalo K, Miettinen M (1999) Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors Cancer 86:2406–2412

    Article  PubMed  CAS  Google Scholar 

  21. Salven P, Lymboussaki A, Heikkila P et al (1998) Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors Am J Pathol 153:103–108

    PubMed  CAS  Google Scholar 

  22. Schmid-Wendtner MH, Baumert J, Eberle J et al (2003) Disease progression in patients with thin cutaneous melanomas (tumour thickness < or = 0.75 mm): clinical and epidemiological data from the Tumour Center Munich 1977–98 Br J Dermatol 149:788–793

    Article  PubMed  Google Scholar 

  23. Schoppmann SF, Birner P, Stockl J et al (2002) Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis Am J Pathol 161:947–956

    PubMed  CAS  Google Scholar 

  24. Shields JD, Borsetti M, Rigby H et al (2004) Lymphatic density and metastatic spread in human malignant melanoma Br J Cancer 90:693–700

    Article  PubMed  CAS  Google Scholar 

  25. Skobe M, Hawighorst T, Jackson DG et al (2001) Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis Nat Med 7:192–198

    Article  PubMed  CAS  Google Scholar 

  26. Stacker SA, Caesar C, Baldwin ME et al (2001) EGF-D promotes the metastatic spread of tumor cells via the lymphatics Nat Med 7:186–191

    Article  PubMed  CAS  Google Scholar 

  27. Stadelmann WK, Reintgen DS (1998) Prognosis in malignant melanoma Hematol Oncol Clin North Am 12:767–796

    Article  PubMed  CAS  Google Scholar 

  28. Torabian S, Kashani-Sabet M (2005) Biomarkers for melanoma Curr Opin Oncol 17:167–171

    Article  PubMed  CAS  Google Scholar 

  29. Valtola R, Salven P, Heikkila P et al (1999) VEGFR−3 and its ligand VEGF-C are associated with angiogenesis in breast cancer Am J Pathol 154:1381–1390

    PubMed  CAS  Google Scholar 

  30. White RR, Stanley WE, Johnson JL et al (2002) Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis Ann Surg 235:879–887

    Article  PubMed  Google Scholar 

  31. Wiley HE, Gonzalez EB, Maki W et al (2001) Expression of CC chemokine receptor−7 and regional lymph node metastasis of B16 murine melanoma J Natl Cancer Inst 93:1638–1643

    Article  PubMed  CAS  Google Scholar 

  32. Zeng Y, Opeskin K, Baldwin ME et al (2004) Expression of vascular endothelial growth factor receptor−3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer Clin Cancer Res 10:5137–5144

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Julius-Maximilians-University Wuerzburg, Josef-Schneider-Strasse 2, 97080 , Wuerzburg, Germany

    Marion Wobser, Claudia Siedel, David Schrama, Eva-B. Bröcker, Juergen C. Becker & Claudia S. Vetter-Kauczok

Authors
  1. Marion Wobser
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claudia Siedel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David Schrama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eva-B. Bröcker
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Juergen C. Becker
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Claudia S. Vetter-Kauczok
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Juergen C. Becker.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wobser, M., Siedel, C., Schrama, D. et al. Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma. Arch Dermatol Res 297, 352–357 (2006). https://doi.org/10.1007/s00403-005-0633-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-005-0633-1

Keywords

Search

Navigation